Genetic Embryo Screening for Psychiatric Risk Not Supported by Evidence, Ethically Questionable
By Jenny Logan,
Mad in America
| 09. 02. 2022
At least one private company has begun offering services to allow parents undergoing in-vitro fertilization (IVF) to screen embryos for complex genetic risks with a procedure called polygenic embryo screening (PES). Although genetic testing of embryos for the risk of some severe diseases with known strong genetic links (cystic fibrosis or Tay-Sachs, for instance) has existed for decades, PES is a new form of screening that these companies claim can identify the risk for complex medical problems, including psychiatric disorders, that do not have specific known risk genes.
However, this approach lacks scientific validity and brings up a host of ethical issues, according to a new article in top-tier psychiatric journal Lancet Psychiatry.
“We are concerned that these tests are being marketed with limited empirical data behind them and virtually no scientific or ethical discussion. Without more research, it is unlikely that medical providers and the general public will have sufficient understanding to evaluate the pros and cons of this technology,” the researchers write.
The authors were led by Todd Lencz, a prolific expert on the genetics of...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...